Bristol-Myers Squibb Co (BMY)
44.70
-4.16
(-8.51%)
USD |
NYSE |
Apr 25, 16:00
44.76
+0.06
(+0.13%)
Pre-Market: 08:20
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 90.39B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -33.63% |
Valuation | |
PE Ratio | 11.58 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.064 |
Price to Book Value | 3.071 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.60 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 1.351 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 39.24% |
Profile
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. |
URL | https://www.bms.com |
Investor Relations URL | https://www.bms.com/investors.html |
HQ State/Province | New Jersey |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Large Cap/Value |
Next Earnings Release | Jul. 26, 2024 |
Last Earnings Release | Apr. 25, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 04, 2024 |
Ratings
Profile
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. |
URL | https://www.bms.com |
Investor Relations URL | https://www.bms.com/investors.html |
HQ State/Province | New Jersey |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Large Cap/Value |
Next Earnings Release | Jul. 26, 2024 |
Last Earnings Release | Apr. 25, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 04, 2024 |